readthroughSign in
CompanyIMNMNasdaqBothell, WA

Immunome, Inc.

Immunome develops targeted oncology therapies including antibody-drug conjugates and radioligand therapy.

SCHEDULE 13GNov 16Latest SEC filing
Nov 9Latest story